Stock Earnings

Question 1

Corbus Pharmaceuticals Holdings Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Corbus Pharmaceuticals Holdings Incの総資産は$155で、純lossは$-40です。

Question 2

CRBPの主要な財務比率は何ですか？

Accepted Answer

Corbus Pharmaceuticals Holdings Incの流動比率は11.92、純利益率は0、1株当たり売上高は$0です。

Question 3

Corbus Pharmaceuticals Holdings Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Corbus Pharmaceuticals Holdings Inc data is not available.

Question 4

Corbus Pharmaceuticals Holdings Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Corbus Pharmaceuticals Holdings Incの純lossは$-40です。

Question 5

Corbus Pharmaceuticals Holdings Incに負債はありますか？

Accepted Answer

yes、Corbus Pharmaceuticals Holdings Incの負債は13です。

Question 6

Corbus Pharmaceuticals Holdings Incの発行済株式数は何株ですか？

Accepted Answer

Corbus Pharmaceuticals Holdings Incの総発行済株式数は12.17株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	3
Revenue Growth (YoY)	--	--	--	--	-100%	-92%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	15	16	14	18	20	28
Research & Development	60	--	31	16	36	98
Operating Expenses	75	49	45	34	56	126
Other Non Operating Income (Expenses)	0	9	3	0	11	13
Pretax Income	-67	-40	-45	-42	-45	-111
Income Tax Expense	--	--	--	--	--	--
Net Income	-67	-40	-45	-42	-45	-111
Net Income Growth	76%	-11%	7%	-7%	-59%	56%
Shares Outstanding (Diluted)	12.3	11	4.33	4.17	4.1	2.6
Shares Change (YoY)	2%	154%	4%	2%	57.99%	22%
EPS (Diluted)	-5.48	-3.63	-10.39	-10.15	-11.13	-42.79
EPS Growth	70%	-65%	2%	-9%	-74%	28%
Free Cash Flow	-59	-41	-36	-37	-48	-100
Free Cash Flow Per Share	-4.79	-3.72	-8.31	-8.87	-11.7	-38.46
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	-4,066.66%
Profit Margin	0%	0%	0%	0%	0%	-3,700%
Free Cash Flow Margin	0%	0%	0%	0%	0%	-3,333.33%
EBITDA	-75	-49	-45	-34	-54	-121
EBITDA Margin	0%	0%	0%	0%	0%	-4,033.33%
D&A For EBITDA	0	0	0	0	1	1
EBIT	-75	-49	-45	-34	-55	-122
EBIT Margin	0%	0%	0%	0%	0%	-4,066.66%
Effective Tax Rate	--	--	--	--	--	--

Corbus Pharmaceuticals Holdings Inc (CRBP) Price